Skip to main content
Article Open Access

Revisiting the link between NADPH oxidase p22phox C242T polymorphism and ischemic stroke risk: an updated meta-analysis

  • and EMAIL logo
Published/Copyright: December 30, 2025

Abstract

The relationship between the NADPH oxidase p22phox C242T and susceptibility to ischemic stroke (IS) has been extensively studied, yet the findings from these studies remain inconsistent. To clarify this association, we conducted an updated meta-analysis of case-control studies. A comprehensive literature search of PubMed, Embase, and CNKI was performed on January 31, 2025. Studies exhibiting Hardy-Weinberg equilibrium (HWE) deviations in the control population were excluded from analysis. Pooled odds ratios (ORs) with corresponding 95 % confidence intervals (CIs) were calculated to evaluate the association across various genetic models. Our meta-analysis included 10 studies, comprising 3,422 cases and 3,410 controls. We found no significant association between the C242T polymorphism and IS susceptibility under any genetic model. Subgroup analyses stratified by ethnicity and IS type similarly revealed no significant increase in risk. Sensitivity analysis confirmed the stability of these pooled results. This updated meta-analysis suggests that the NADPH oxidase p22phox C242T polymorphism lacks a significant association with ischemic stroke risk. Nevertheless, larger and more diverse population studies are warranted to confirm these findings.

1 Introduction

Ischemic stroke (IS) is a complex multifactorial disorder resulting from the interplay of genetic predispositions and environmental factors such as hypertension, diabetes, hyperlipidemia, and smoking [1]. As a major global public health concern, IS imposes a substantial burden on families, communities, and healthcare systems. Genetic factors are increasingly recognized as key contributors to IS susceptibility, with several gene polymorphisms implicated in its pathogenesis [2], [3], [4]. Atherosclerosis, a primary cause of ischemic cerebrovascular disease, involves accelerated lipid peroxidation driven by elevated levels of reactive oxygen species (ROS) [5], [6], [7], [8]. A major enzymatic source of ROS is the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex [9].

The NADPH oxidase complex, which includes membrane subunits such as gp91phox (NOX2) and p22phox, as well as cytosolic components like p47phox, p67phox, p40phox, and Rac2, is a key source of ROS production [10], [11], [12]. The CYBA gene, which encodes the p22phox protein, is located on the long arm of chromosome 16 and exhibits several allelic variants [13], [14], [15]. One notable variant is the C242T polymorphism, which involves an amino acid substitution (His/Tyr) at residue 72, causing significant morphological changes in the extracellular loop of the p22phox protein. This polymorphism may disrupt the interaction between p22phox and the catalytic subunit NOX2, potentially reducing ROS production by NADPH oxidase [16].

In the past few decades, numerous studies have investigated the relationship between the p22phox C242T polymorphism and the risk of ischemic cerebrovascular disease [17], [18], [19]. However, results have been inconsistent, with some studies suggesting an association and others reporting none [20], [21], [22]. This inconsistency is further complicated by potential population stratification and deviations from Hardy-Weinberg equilibrium (HWE) in control groups. Therefore, the objective of this updated meta-analysis was to quantitatively synthesize the most recent evidence to reassess the association between the NADPH oxidase p22phox C242T polymorphism and ischemic stroke risk.

2 Materials and methods

2.1 Literature search

We conducted an extensive electronic search of relevant studies in PubMed, Embase, and the China National Knowledge Infrastructure (CNKI) up to January 2025. Search keywords included “NADPH,” “p22phox,” “C242T,” “rs4673,” “polymorphism,” and “ischemic stroke.” Our aim was to identify all eligible case-control studies exploring the association between the p22phox C242T polymorphism and ischemic stroke (IS) susceptibility.

2.2 Selection criteria and quality assessment

Studies were included if they met the following criteria: (1) case-control design evaluating the association between the p22phox C242T polymorphism and IS susceptibility; and (2) provision of sufficient data on genotype and allele frequencies. Studies were excluded if: (1) control groups deviated from Hardy-Weinberg equilibrium (HWE); or (2) they were duplicate publications. Maintaining HWE in control groups is essential for minimizing genotype errors and preventing population stratification biases. Two authors independently assessed the quality of included articles using the Newcastle-Ottawa Scale, which encompasses eight key criteria: adequate case determination, representativeness of cases, control selection, control determination, comparability between cases and controls, exposure ascertainment, uniform ascertainment methods for both groups, and non-response rate [23].

2.3 Data extraction

For each study, we extracted the following information: first author’s surname, publication year, ethnic group, country of origin, sample size, IS subtype, and genotype frequency. This detailed data extraction enabled us to compile comprehensive information for our meta-analysis.

2.4 Statistical analysis

Given that some studies reported zero frequency for the TT genotype, we applied four genetic models for analysis: the allelic model (T allele vs. C allele), the dominant model (TT + TC vs. CC), the overdominant model (TC vs. TT + CC), and the codominant model (TC vs. CC). We calculated odds ratios (ORs) and 95 % confidence intervals (CIs) from each study to assess the association between the p22phox C242T polymorphism and IS susceptibility. Heterogeneity across studies was evaluated using the chi-square test and I2 statistic. Meta-regression was performed using the method of moments to identify sources of heterogeneity. Both fixed-effects and random-effects models were applied and compared to ensure robustness. Subgroup analyses were conducted based on IS subtypes and ethnicity to explore potential differences. Sensitivity analysis was performed by sequentially removing individual studies to assess the stability of the pooled results. Publication bias was evaluated using funnel plots and Egger’s regression test. Statistical analyses were conducted using MetaGenyo, a web-based tool for meta-analysis of genetic association studies (https://metagenyo.genyo.es/). If publication bias was detected, the trim-and-fill method was applied using the R package ‘meta’ to assess whether this bias affected the combined effect size results.

3 Results

3.1 Literature search and study characteristics

Our comprehensive search across PubMed, Embase, and CNKI identified 195 articles. After screening titles and abstracts, we selected 15 studies for detailed evaluation [17], [18], [19, [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35]. Upon thorough review, five articles were excluded based on predefined criteria [17], [18], [19, 24], 32] (Supplementary data). Specifically, one study lacked sufficient genotype and allele frequency data [17], while four others deviated from HWE in their control groups [18], 19], 24], 32]. Ultimately, 10 studies were included in our meta-analysis, encompassing 3,422 cases and 3,410 controls [25], [26], [27], [28], [29], [30], [31, [33], [34], [35] (Figure 1). The characteristics of these studies are summarized in Table 1, and the detailed distribution of alleles and genotypes is presented in Table 2. Following rigorous quality assessment, all included studies were rated as medium or high quality, with scores ranging from 5 to 9.

Figure 1: 
Flow of studies through the review process.
Figure 1:

Flow of studies through the review process.

Table 1:

Baseline characteristics of included studies.

First author, Year of publication Country Ethnicity Sample size Age (Mean ± SD, y) Subtype of IS
Case Control Case Control
Han [25] China East Asian 76 105 64.92 ± 11.1 63.91 ± 11.9 SVO and LAA
Ito [26] Japan East Asian 203 301 58 ± 8 59 ± 4 SVO and LAA
Jiang [35] China East Asian 185 183 66.31 ± 10.82 67.91 ± 12.27 SVO and LAA
Kovaleva [33] Russia Caucasian 746 500 67.89 ± 0.42 54.42 ± 0.55 SVO and LAA
Kuroda [27] Japan East Asian 1,055 1,055 70 ± 10 70 ± 10 SVO, LAA, CE and SUE
Li [21], 28] China East Asian 125 147 65.42 ± 11.65 65.22 ± 9.69 SVO and LAA
Li [34] China East Asian 284 335 61.46 ± 10.52 60.17 ± 9.56 SVO and LAA
Niemierc [29] Poland Caucasian 70 50 8.48 ± 5.44 9.0 ± 6.1 SVO, LAA and SUE
Shimo-Nakanishi [30] Japan East Asian 120 177 61.2 ± 11.4 58.9 ± 9.25 SVO and LAA
Yan [31] China East Asian 558 557 61.0 ± 9.8 62.2 ± 9.3 SVO and LAA
  1. IS, ischemic stroke; SVO, small-vessel occlusion; LAA, large-artery atherosclerosis; CE, cardioembolism; SUE, stroke of undetermined etiology.

Table 2:

Distribution of p22phox C242T genotypes and allelic frequency.

Study

First author (years)
Distribution of p22phox C242T genotype Frequency of p22phox C242T alleles HWE

P Value
CC CT TT C T
Cases n Controls n Cases n Controls n Cases n Controls n Cases n Controls n Cases n Controls n
Han [25] 61 99 15 6 0 0 137 204 15 6 0.763
Ito [26] 158 261 42 38 3 2 358 560 48 42 0.634
Jiang [35] 162 173 20 10 3 0 344 356 26 10 0.704
Kovaleva [33] 351 240 302 206 93 54 1,004 686 488 314 0.329
Kuroda [27] 851 840 189 198 15 17 1,891 1,878 219 232 0.181
Li [21], 28] 113 144 11 3 1 0 237 291 13 3 0.900
Li [34] 231 261 51 71 2 3 513 593 55 77 0.444
Niemierc [29] 35 26 27 18 8 6 97 70 43 30 0.312
Shimo-Nakanishi [30] 102 154 18 23 0 0 222 331 18 23 0.355
Yan [31] 487 471 71 85 0 1 1,045 1,027 71 87 0.158

3.2 Meta-analysis findings

Our meta-analysis revealed no significant association between the p22phox C242T polymorphism and ischemic stroke susceptibility in any genetic model. Specifically, the allelic model (T vs. C) showed an odds ratio (OR) of 1.22 with a 95 % confidence interval (CI) of 0.96–1.54 (p = 0.11). The dominant model (TT + TC vs. CC) yielded an OR of 1.23 (95 % CI: 0.95–1.59, p = 0.11), while the overdominant model (TC vs. TT + CC) had an OR of 1.19 (95 % CI: 0.93–1.52, p = 0.17). The codominant model (TC vs. CC) resulted in an OR of 1.20 (95 % CI: 0.94–1.54, p = 0.15). These results are visually represented in Figure 2.

Figure 2: 
Forest plot analysis evaluating the association between NADPH oxidase p22phox C242T polymorphism and ischemic stroke (IS) risk. The analysis includes four genetic models: (A) Allelic model comparing the T allele to the C allele; (B) dominant model combining TT and TC genotypes against CC genotype; (C) overdominant model comparing TC genotype to the combined TT and CC genotypes; (D) codominant model comparing TC genotype to CC genotype.
Figure 2:

Forest plot analysis evaluating the association between NADPH oxidase p22phox C242T polymorphism and ischemic stroke (IS) risk. The analysis includes four genetic models: (A) Allelic model comparing the T allele to the C allele; (B) dominant model combining TT and TC genotypes against CC genotype; (C) overdominant model comparing TC genotype to the combined TT and CC genotypes; (D) codominant model comparing TC genotype to CC genotype.

3.3 Heterogeneity and subgroup analyses

Significant heterogeneity was observed across all genetic models in the overall analysis, with I2 statistics exceeding 50 % and p-values below 0.05. Subsequent meta-regression analysis failed to identify any significant influence of ethnicity or IS type on IS risk. Subgroup analyses stratified by ethnicity and IS subtype similarly revealed no significant associations under any genetic model (Table 3). Notably, heterogeneity markedly decreased in studies focusing on small-vessel occlusion and large-artery atherosclerosis (LAA) and no heterogeneity was observed in Caucasians (Supplementary data), suggesting that these factors may have distinct genetic influences.

Table 3:

Odds ratios (ORs) and heterogeneity results for the genetic contrasts of C242T for IS.

Population OR I2 (%) P-val

Q test
P-val

Egger’s test
Fixed effects (95 % CI) P Random effects (95 % CI) P
Allele contrast (T vs. C) All 1.05 [0.95–1.17] 0.35 1.22 [0.96–1.54] 0.10 70.43 0.0004 0.0352
Caucasian 1.06 [0.90–1.25] 0.49 1.06 [0.90–1.25] 0.49 0 0.9298 NA
East Asian 1.05 [0.91–1.20] 0.51 1.37 [0.97–1.93] 0.07 76.98 0.0001 0.0173
Japanese 1.05 [0.89–1.25] 0.55 1.22 [0.78–1.89] 0.38 72.03 0.028 0.4829
Chinese 1.03 [0.83–1.29] 0.76 1.70 [0.90–3.20] 0.10 82.79 0.0001 0.0023
Adult 1.05 [0.95–1.17] 0.35 1.25 [0.97–1.61] 0.09 73.71 0.0002 0.0347
LAA 1.03 [0.85–1.25] 0.75 1.07 [0.80–1.44] 0.15 43.83 0.1485 0.5224
SVO 1.08 [0.88–1.31] 0.47 1.11 [0.75–1.63] 0.61 61.38 0.051 0.8318
Dominant model (TT + TC vs. CC) All 1.05 [0.93–1.18] 0.45 1.23 [0.95–1.59] 0.11 68.47 0.0008 0.0188
Caucasian 1.05 [0.84–1.29] 0.71 1.05 [0.84–1.29] 0.71 0 0.9139 NA
East Asian 1.05 [0.90–1.22] 0.51 1.22 [0.96–1.54] 0.10 75.47 0.0002 0.0165
Japanese 1.06 [0.88–1.28] 0.52 1.23 [0.78–1.96] 0.37 70.93 0.0321 0.4755
Chinese 1.03 [0.82–1.30] 0.79 1.67 [0.88–3.17] 0.12 81.49 0.0002 0.0022
Adult 1.05 [0.93–1.18] 0.46 1.26 [0.95–1.65] 0.10 71.97 0.0004 0.0169
LAA 1.03 [0.83–1.27] 0.82 1.10 [0.77–1.56] 0.61 53.83 0.0897 0.4429
SVO 1.09 [0.88–1.35] 0.43 1.11 [0.75–1.65] 0.60 57.36 0.0708 0.8637
Overdominant model (TC vs. TT + CC) All 1.03 [0.91–1.16] 0.67 1.19 [0.93–1.52] 0.16 64.06 0.0029 0.0121
Caucasian 0.98 [0.79–1.22] 0.87 0.98 [0.79–1.22] 0.87 0 0.7277 NA
East Asian 1.05 [0.90–1.22] 0.53 1.32 [0.94–1.84] 0.11 71.65 0.0009 0.0163
Japanese 1.07 [0.88–1.29] 0.51 1.22 [0.79–1.88] 0.37 65.88 0.0533 0.467
Chinese 1.02 [0.81–1.30] 0.86 1.57 [0.86–2.88] 0.14 78.67 0.0009 0.0026
Adult 1.03 [0.90–1.16] 0.70 1.21 [0.93–1.57] 0.16 67.99 0.0016 0.0115
LAA 1.02 [0.82–1.26] 0.88 1.11 [0.76–1.62] 0.60 59.22 0.0614 0.3985
SVO 1.10 [0.88–1.37] 0.41 1.10 [0.77–1.58] 0.59 48.46 0.1207 0.9248
Codominant model (TC vs. CC) All 1.04 [0.92–1.18] 0.56 1.20 [0.94–1.54] 0.15 68.47 0.0004 0.014
Caucasian 1.01 [0.80–1.27] 0.92 1.01 [0.80–1.27] 0.92 0 0.8002 NA
East Asian 1.05 [0.90–1.22] 0.53 1.32 [0.94–1.86] 0.10 72.23 0.0007 0.0162
Japanese 1.07 [0.88–1.29] 0.51 1.22 [0.79–1.90] 0.37 67.18 0.0475 0.4683
Chinese 1.02 [0.81–1.29] 0.86 1.58 [0.86–2.91] 0.14 78.98 0.0008 0.0026
Adult 1.04 [0.91–1.18] 0.59 1.22 [0.96–1.54] 0.14 70.43 0.0004 0.0352
LAA 1.02 [0.82–1.26] 0.86 1.11 [0.76–1.61] 0.60 58.41 0.0654 0.4036
SVO 1.10 [0.88–1.37] 0.41 1.11 [0.77–1.60] 0.59 50.22 0.1103 0.908
  1. IS, ischemic stroke; SVO, small-vessel occlusion; LAA, large-artery atherosclerosis; Not applicable, NA.

3.4 Sensitivity and publication bias analyses

Sensitivity analysis, performed by sequentially removing individual studies, indicated that our findings were robust, with no single study significantly influencing the overall results. Publication bias was assessed using funnel plots and Egger’s regression test. While publication bias was detected in all genetic models (p-values ranging from 0.012 to 0.035), it was absent in studies of small-vessel occlusion and large-artery atherosclerosis. The results remained unchanged after adjusting for publication bias using the trim-and-fill method in the allelic model (OR 1.027, 95 % CI 0.693–1.523; p = 0.892; Figure 3).

Figure 3: 
The adjusted funnel plot for the allelic model following adjustment with the trim-and-fill method. Solid circles denote the original studies, while hollow circles represent the imputed ones, respectively.
Figure 3:

The adjusted funnel plot for the allelic model following adjustment with the trim-and-fill method. Solid circles denote the original studies, while hollow circles represent the imputed ones, respectively.

4 Discussion

Ischemic stroke (IS) is a complex pathological condition characterized by reduced blood flow and oxygen supply to brain tissue. The precise mechanisms linking NADPH oxidase to ischemic stroke remain unclear, although reactive oxygen species (ROS) have been implicated in its pathophysiology [10], 36]. NADPH oxidase is a key enzyme complex responsible for ROS production in the brain [36], 37]. Previous studies have suggested that superoxide-producing NADPH oxidases are associated with ischemia-reperfusion injury in the brain [38]. The C242T polymorphism in the p22phox subunit may disrupt the interaction between p22phox and NOX2 [16], potentially reducing ROS production [39], 40]. However, our meta-analysis did not identify a significant association between the p22phox C242T polymorphism and the risk of ischemic stroke, despite the presence of publication bias. This bias typically stems from the systematic under-reporting of small-scale studies with null or negative findings, consequently leading to an overestimation of the true effect size within meta-analyses. Therefore, the pooled ORs observed before adjustment should be interpreted as representing the probable upper bound of any potential association. Crucially, however, the robustness of our primary finding, a demonstrable lack of significant association, is robustly reinforced by both sensitivity analyses and the trim-and-fill method. The application of the trim-and-fill method, which imputes theoretically missing studies to correct funnel plot asymmetry, resulted in an adjusted effect size even closer to the null value (OR 1.027) that remained non-significant. This compellingly suggests that, even after accounting for potential publication bias, the conclusion of no association remains statistically robust.

Our null findings stand in stark contrast to earlier meta-analyses reporting a significant association between the C242T polymorphism and ischemic cerebrovascular disease [21], 22]. This discrepancy is largely ascribed to a critical methodological refinement in our study. Previous analyses incorporated primary studies where control groups significantly deviated from Hardy-Weinberg Equilibrium (HWE). Such deviations are a well-established indicator of potential genotyping errors, population stratification, or selection bias, which can significantly distort true genetic effect estimates in meta-analyses [41]. By rigorously excluding studies with HWE violations in controls, our analysis provides a more accurate and reliable pooled estimate. This methodological rigor aligns our results with the well-designed, null-finding study by Gu et al. [20] and highlights the critical importance of quality control in genetic association syntheses. Therefore, the principal contribution of this updated meta-analysis lies not merely in its recency, but in its application of a more stringent methodological standard, suggesting earlier positive associations may have been biased.

Furthermore, the relationship between the C242T polymorphism and ROS production is complex. Studies have shown that the T242 allele is associated with reduced NADPH oxidase activity and lower ROS levels in vascular cells [42], 43]. Arca et al. demonstrated that the T242 allele predicts a lower risk of recurrent cardiovascular events and is linked to reduced systemic oxidative stress [44]. In CC individuals, augmented NADPH oxidase activity was unrelated to elevated p22phox expression levels, implying that the C242T polymorphism disrupts the binding capacity of p22phox to gp91phox, thereby modulating NADPH oxidase function [42]. However, other research has reported no significant effect of the C242T polymorphism on oxidative stress levels in healthy individuals at rest [45]. These conflicting findings highlight the need for further research, particularly in larger and more diverse populations, to elucidate the role of this polymorphism in ischemic stroke.

The striking reduction in heterogeneity observed within specific subgroups, such as small-vessel occlusion (SVO) and Caucasian populations, warrants further consideration. Biologically, this may indicate a more homogeneous pathogenic role for NADPH oxidase-derived ROS in these distinct stroke etiologies or genetic backgrounds. For instance, the pathophysiology of SVO closely links to cerebral microangiopathy and endothelial dysfunction, processes where NADPH oxidase activity is profoundly implicated. The absence of significant heterogeneity in Caucasians could reflect a more uniform genetic architecture and a lower degree of population stratification compared to more diverse ethnic groups, thereby simplifying the genetic association and thus reinforcing this specific link.

Several limitations of our meta-analysis should be acknowledged. First, our findings rest primarily on unadjusted effect estimates. A notable limitation of this approach is its failure to adjust for potential confounding variables like age, hypertension, smoking status, diabetes, and lipid profiles. These factors are established independent predictors of IS and may also influence oxidative stress levels, thereby acting as confounders or effect modifiers in the genotype-phenotype relationship. The primary studies’ lack of adjustment for these variables introduces the risk that residual confounding could bias our pooled estimates. Consequently, the null association we observed might mask a subtle genuine association obscured by confounding, or conversely, bolster the evidence for a true null finding if such pervasive confounding existed yet still yielded no signal. Future meta-analyses incorporating individual-level data or adjusted estimates would be critical for providing more precise and confounder-resistant summary estimates. Second, our analysis is confined to published studies, which may introduce publication bias. The inclusion of unpublished studies with nonsignificant or negative results could alter the pooled estimate and provide a more balanced understanding of the true association. Third, the generalizability of our conclusions may be limited due to the ethnic diversity of the included studies. Only two studies focused exclusively on Caucasian populations, restricting statistical power and applicability to other ethnic groups. Fourth, while our meta-analysis found no statistically significant correlation, it is possible that a small true effect exists below the detection threshold of the available sample size, or that complex gene-environment interactions obscured a true relationship. Finally, the significant statistical heterogeneity across studies may affect the precision and robustness of our pooled estimate.

In summary, our meta-analysis suggests that the NADPH oxidase p22phox C242T polymorphism does not confer a significant risk for ischemic stroke. However, further large-scale studies with diverse populations are needed to validate these findings. Additionally, exploring potential interactions between the p22phox C242T polymorphism and other genetic or environmental factors may provide deeper insights into its role in ischemic stroke susceptibility.


Corresponding author: Li An, Department of Gerontology, Zhongda Hospital Southeast University, Nanjing, People’s Republic of China, E-mail:

Funding source: Jiangsu Provincial Research Projects on Geriatric Health

Award Identifier / Grant number: LKM2024020

Acknowledgements

We gratefully acknowledge the support and resources provided by Nanjing BenQ Medical Center in conducting this study.

  1. Funding information: Jiangsu Provincial Research Projects on Geriatric Health (LKM2024020).

  2. Author contribution: L.A. and Y.W.: Drafting the manuscript, Interpretation of data; L.A. and Y.W.: Acquisition of data; L.A. and Y.W.: Data analysis; L.A.: Revise the manuscript; L.A.: conception and design, supervising. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

1. Jiang, M, Yin, P, Bai, X, Yang, L, Zhang, J, Xu, S. Proinflammatory and anti-inflammatory genes in stroke pathogenesis. Curr Pharm Des 2020;26:4220–33. https://doi.org/10.2174/1381612826666200701212859.Search in Google Scholar PubMed

2. Deng, XD, Ke, JL, Chen, TY, Gao, Q, Zhao, ZL, Zhang, W, et al.. ERCC1 polymorphism and its expression associated with ischemic stroke in Chinese population. Front Neurol 2023;13:998428. https://doi.org/10.3389/fneur.2022.998428.Search in Google Scholar PubMed PubMed Central

3. Wang, M, Shen, Y, Gao, Y, Chen, H, Duan, F, Li, S, et al.. NQO1 polymorphism and susceptibility to ischemic stroke in a Chinese population. BMC Med Genomics 2024;17:219. https://doi.org/10.1186/s12920-024-01992-7.Search in Google Scholar PubMed PubMed Central

4. Wang, P, Lu, J, Wang, M, Wang, G, Chen, H. NRF2 polymorphism and susceptibility to ischemic stroke in a Chinese population. PeerJ 2025;13:e19742. https://doi.org/10.7717/peerj.19742.Search in Google Scholar PubMed PubMed Central

5. Sarmah, D, Datta, A, Raut, S, Sarkar, A, Shah, B, Bohra, M, et al.. The role of inflammasomes in atherosclerosis and stroke pathogenesis. Curr Pharm Des 2020;26:4234–45. https://doi.org/10.2174/1381612826666200427084949.Search in Google Scholar PubMed

6. Batty, M, Bennett, MR, Yu, E. The role of oxidative stress in atherosclerosis. Cells 2022;11:3843. https://doi.org/10.3390/cells11233843.Search in Google Scholar PubMed PubMed Central

7. Koutsaliaris, IK, Moschonas, IC, Pechlivani, LM, Tsouka, AN, Tselepis, AD. Inflammation, oxidative stress, vascular aging and atherosclerotic ischemic stroke. Curr Med Chem 2022;29:5496–509. https://doi.org/10.2174/0929867328666210921161711.Search in Google Scholar PubMed

8. Yan, R, Zhang, X, Xu, W, Li, J, Sun, Y, Cui, S, et al.. ROS-induced endothelial dysfunction in the pathogenesis of atherosclerosis. Aging Dis 2024;16:250–68. https://doi.org/10.14336/AD.2024.0309.Search in Google Scholar PubMed PubMed Central

9. Hou, E, Yan, J, Zhu, X, Qiao, J. High-salt diet contributes to excess oxidative stress and abnormal metabolism in mouse ovaries. Biomed Chromatogr 2022;36:e5500. https://doi.org/10.1002/bmc.5500.Search in Google Scholar PubMed

10. Lam, GY, Huang, J, Brumell, JH. The many roles of NOX2 NADPH oxidase-derived ROS in immunity. Semin Immunopathol 2010;32:415–30. https://doi.org/10.1007/s00281-010-0221-0.Search in Google Scholar PubMed

11. Babior, BM. NADPH oxidase: an update. Blood 1999;93:1464–76. https://doi.org/10.1182/blood.v93.5.1464.Search in Google Scholar

12. DeLeo, FR, Renee, J, McCormick, S, Nakamura, M, Apicella, M, Weiss, JP, et al.. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Investig 1998;101:455–63. https://doi.org/10.1172/jci949.Search in Google Scholar PubMed PubMed Central

13. Soccio, M, Toniato, E, Evangelista, V, Carluccio, M, De Caterina, R. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest 2005;35:305–14. https://doi.org/10.1111/j.1365-2362.2005.01500.x.Search in Google Scholar PubMed

14. Ushio-Fukai, M, Zafari, AM, Fukui, T, Ishizaka, N, Griendling, KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996;271:23317–21. https://doi.org/10.1074/jbc.271.38.23317.Search in Google Scholar PubMed

15. Rae, J, Noack, D, Heyworth, PG, Ellis, BA, Curnutte, JT, Cross, AR. Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22(phox). Blood 2000;96:1106–12. https://doi.org/10.1182/blood.v96.3.1106.015k44_1106_1112.Search in Google Scholar

16. Stasia, MJ. CYBA encoding p22(phox), the cytochrome b558 alpha polypeptide: gene structure, expression, role and physiopathology. Gene 2016;586:27–35. https://doi.org/10.1016/j.gene.2016.03.050.Search in Google Scholar PubMed PubMed Central

17. Khan, U, Bevan, S, Markus, HS. NADPH oxidase polymorphisms in cerebral small vessel disease. Cerebrovasc Dis 2007;24:135–8. https://doi.org/10.1159/000103615.Search in Google Scholar PubMed

18. Chen, N, Fu, Y, Ying, YY, Ni, PH. Correlation between NAD(P)H oxidase p22phox C242T polymorphism and cerebral infarction. Lab Med 2011;26:175–9. [Chinese].Search in Google Scholar

19. Genius, J, Grau, AJ, Lichy, C. The C242T polymorphism of the NAD(P)H oxidase p22phox subunit is associated with an enhanced risk for cerebrovascular disease at a young age. Cerebrovasc Dis 2008;26:430–3. https://doi.org/10.1159/000155639.Search in Google Scholar PubMed

20. Gu, L, Su, L, Liang, B, Tang, N, Long, J, Tan, J, et al.. Association between the C242T polymorphism of p22phox gene and ischemic stroke: a meta-analysis. J Neurol Sci 2013;330:100–10. https://doi.org/10.1016/j.jns.2013.04.022.Search in Google Scholar PubMed

21. Li, BH, Zhang, LL, Zhang, BB, Yin, YW, Dai, LM, Pi, Y, et al.. Association between NADPH oxidase p22(phox) C242T polymorphism and ischemic cerebrovascular disease: a meta-analysis. PLoS One 2013;8:e56478. https://doi.org/10.1371/journal.pone.0056478.Search in Google Scholar PubMed PubMed Central

22. Li, P, Qiu, T, Qin, C. NADPH oxidase p22phox C242T polymorphism and ischemic cerebrovascular disease: an updated meta-analysis. Med Sci Monit 2015;21:231–8. https://doi.org/10.12659/msm.892253.Search in Google Scholar

23. Wells, GA, Shea, B, O’Connell, D, Peterson, J, Welch, V, Losos, M, et al.. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2022. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.Search in Google Scholar

24. Sharma, A, Saleem, S, Verma, S, Afroze, D. C242T polymorphism of P22phox gene of the nox: a putative pathological risk factor for stroke in Kashmiri population. J Neurol Stroke 2014;1:00020. https://doi.org/10.15406/jnsk.2014.01.00020.Search in Google Scholar

25. Han, HX, Li, XX, Zhang, C. Correlation between NAD(P)H oxidase p22phox C242T polymorphism and ischemic cerebrovascular diseases. Cerebrovasc Dis Foreign Med Sci 2004;12:183–6.Search in Google Scholar

26. Ito, D, Murata, M, Watanabe, K, Yoshida, T, Saito, I, Tanahashi, N, et al.. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 2000;31:936–9. https://doi.org/10.1161/01.str.31.4.936.Search in Google Scholar PubMed

27. Kuroda, J, Kitazono, T, Ago, T, Ninomiya, T, Ooboshi, H, Kamouchi, M, et al.. NAD(P)H oxidase p22phox C242T polymorphism and ischemic stroke in Japan: the fukuoka stroke registry and the hisayama study. Eur J Neurol 2007;14:1091–7. https://doi.org/10.1111/j.1468-1331.2007.01904.x.Search in Google Scholar PubMed

28. Li, H, Gu, B, Yu, FP, Zhao, YC, Lou, XL, Liang, DY. The relationship between NAD(P)H oxidase p22phox C242T polymorphism and stroke in the population of Han nationality of Shanghai city. Nanjing Yike Daxue Xuebao 2013;33:1081–6.Search in Google Scholar

29. Niemiec, P, Zak, I, Emich-Widera, E, Balcerzyk, A, Kopyta, I, Nowak, T, et al.. The C242T polymorphism of the gene encoding cytochrome b-245 alpha is not associated with paediatric ischaemic stroke: family-based and case-control study. Neurol Neurochir Pol 2010;44:453–8. https://doi.org/10.1016/s0028-3843(14)60135-3.Search in Google Scholar PubMed

30. Shimo-Nakanishi, Y, Hasebe, T, Suzuki, A, Mochizuki, H, Nomiyama, T, Tanaka, Y, et al.. Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 2004;175:109–15. https://doi.org/10.1016/j.atherosclerosis.2004.01.043.Search in Google Scholar PubMed

31. Yan, JT, Zhang, L, Xu, YJ, Wang, XJ, Wang, CY, Wang, DW. Polymorphisms of genes in nitric oxide-forming pathway associated with ischemic stroke in Chinese Han population. Acta Pharmacol Sin 2011;32:1357–63. https://doi.org/10.1038/aps.2011.114.Search in Google Scholar PubMed PubMed Central

32. Ji, Z, Lu, BX. Relationship of the C242T p22phox gene polymorphism to cerebral infarction 2001 [Thesis].Search in Google Scholar

33. Kovaleva, EV, Doronin, BM, Morozov, VV, Seryapina, YV, Markova, SG. Correlation of the genetic profile and features of the rehabilitation after ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova 2018;118:22–7. https://doi.org/10.17116/jnevro201811809122.Search in Google Scholar PubMed

34. Li, XX, Liu, WJ, Jiang, WJ, Li, Q, Zhu, RX, Liu, X, et al.. Association between polymorphisms of NADPH oxidase p22phox subunit and ischemic stroke. Chin J Clin Neurosci 2017;25:481–7.Search in Google Scholar

35. Jiang, P, Li, L, Gu, B, Yu, F, Pan, X, Yang, Z, et al.. Association of NAD(P)H oxidase C242T gene polymorphism with lipid level and lipid metabolism of patients with cerebral infarction from Shongjiang Shanghai. Chin J Neuromed 2016;15:164–71.Search in Google Scholar

36. Duan, J, Gao, S, Tu, S, Lenahan, C, Shao, A, Sheng, J. Pathophysiology and therapeutic potential of NADPH oxidases in ischemic stroke-induced oxidative stress. Oxid Med Cell Longev 2021;2021:6631805. https://doi.org/10.1155/2021/6631805.Search in Google Scholar PubMed PubMed Central

37. Park, MW, Cha, HW, Kim, J, Kim, JH, Yang, H, Yoon, S, et al.. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer’s diseases. Redox Biol 2021;41:101947. https://doi.org/10.1016/j.redox.2021.101947.Search in Google Scholar PubMed PubMed Central

38. Kyung, HW, Lee, S, Kwon, H, Kim, S, Kim, JH, Song, SH, et al.. The effect of botulinum toxin A on the NADPH oxidase system and ischemia-reperfusion injury. Plast Reconstr Surg 2024;154:100e–111e. https://doi.org/10.1097/prs.0000000000010956.Search in Google Scholar

39. Chen, H, Song, YS, Chan, PH. Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J Cerebr Blood Flow Metabol 2009;29:1262–72. https://doi.org/10.1038/jcbfm.2009.47.Search in Google Scholar PubMed PubMed Central

40. Dao, VT, Elbatreek, MH, Altenhöfer, S, Casas, AI, Pachado, MP, Neullens, CT, et al.. Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation. Free Radic Biol Med 2020;148:60–9. https://doi.org/10.1016/j.freeradbiomed.2019.12.038.Search in Google Scholar PubMed

41. Neamatzadeh, H, Dastgheib, SA, Mazaheri, M, Masoudi, A, Shiri, A, Omidi, A, et al.. Hardy-weinberg equilibrium in meta-analysis studies and large-scale genomic sequencing era. Asian Pac J Cancer Prev 2024;25:2229–35. https://doi.org/10.31557/apjcp.2024.25.7.2229.Search in Google Scholar PubMed PubMed Central

42. San, JG, Fortuño, A, Beloqui, O, Díez, J, Zalba, G. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci (Lond) 2008;114:173–82. https://doi.org/10.1042/CS20070130.Search in Google Scholar PubMed

43. Moreno, MU, Zalba, G. CYBA gene variants as biomarkers for coronary artery disease. Drug News Perspect 2010;23:316–24. https://doi.org/10.1358/dnp.2010.23.5.1437711.Search in Google Scholar PubMed

44. Arca, M, Conti, B, Montali, A, Pignatelli, P, Campagna, F, Barillà, F, et al.. C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery disease. Arterioscler Thromb Vasc Biol 2008;28:752–7. https://doi.org/10.1161/atvbaha.107.154823.Search in Google Scholar

45. Cho, SY, So, WY, Roh, HT. The p22phox polymorphism C242T is not associated with peripheral malondialdehyde and superoxide dismutase levels in healthy Korean adults. Iran J Public Health 2019;48:977–9.10.18502/ijph.v48i5.1832Search in Google Scholar


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/biol-2025-1221).


Received: 2025-06-25
Accepted: 2025-10-27
Published Online: 2025-12-30

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Safety assessment and modulation of hepatic CYP3A4 and UGT enzymes by Glycyrrhiza glabra aqueous extract in female Sprague–Dawley rats
  2. Adult-onset Still’s disease with hemophagocytic lymphohistiocytosis and minimal change disease
  3. Role of DZ2002 in reducing corneal graft rejection in rats by influencing Th17 activation via inhibition of the PI3K/AKT pathway and downregulation of TRAF1
  4. Biomedical Sciences
  5. Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
  6. Maslinic acid improves mitochondrial function and inhibits oxidative stress and autophagy in human gastric smooth muscle cells
  7. Comparative analysis of inflammatory biomarkers for the diagnosis of neonatal sepsis: IL-6, IL-8, SAA, CRP, and PCT
  8. Post-pandemic insights on COVID-19 and premature ovarian insufficiency
  9. Proteome differences of dental stem cells between permanent and deciduous teeth by data-independent acquisition proteomics
  10. Optimizing a modified cetyltrimethylammonium bromide protocol for fungal DNA extraction: Insights from multilocus gene amplification
  11. Preliminary analysis of the role of small hepatitis B surface proteins mutations in the pathogenesis of occult hepatitis B infection via the endoplasmic reticulum stress-induced UPR-ERAD pathway
  12. Efficacy of alginate-coated gold nanoparticles against antibiotics-resistant Staphylococcus and Streptococcus pathogens of acne origins
  13. Battling COVID-19 leveraging nanobiotechnology: Gold and silver nanoparticle–B-escin conjugates as SARS-CoV-2 inhibitors
  14. Neurodegenerative diseases and neuroinflammation-induced apoptosis
  15. Impact of fracture fixation surgery on cognitive function and the gut microbiota in mice with a history of stroke
  16. COLEC10: A potential tumor suppressor and prognostic biomarker in hepatocellular carcinoma through modulation of EMT and PI3K-AKT pathways
  17. High-temperature requirement serine protease A2 inhibitor UCF-101 ameliorates damaged neurons in traumatic brain-injured rats by the AMPK/NF-κB pathway
  18. SIK1 inhibits IL-1β-stimulated cartilage apoptosis and inflammation in vitro through the CRTC2/CREB1 signaling
  19. Rutin–chitooligosaccharide complex: Comprehensive evaluation of its anti-inflammatory and analgesic properties in vitro and in vivo
  20. Knockdown of Aurora kinase B alleviates high glucose-triggered trophoblast cells damage and inflammation during gestational diabetes
  21. Calcium-sensing receptors promoted Homer1 expression and osteogenic differentiation in bone marrow mesenchymal stem cells
  22. ABI3BP can inhibit the proliferation, invasion, and epithelial–mesenchymal transition of non-small-cell lung cancer cells
  23. Changes in blood glucose and metabolism in hyperuricemia mice
  24. Rapid detection of the GJB2 c.235delC mutation based on CRISPR-Cas13a combined with lateral flow dipstick
  25. IL-11 promotes Ang II-induced autophagy inhibition and mitochondrial dysfunction in atrial fibroblasts
  26. Short-chain fatty acid attenuates intestinal inflammation by regulation of gut microbial composition in antibiotic-associated diarrhea
  27. Application of metagenomic next-generation sequencing in the diagnosis of pathogens in patients with diabetes complicated by community-acquired pneumonia
  28. NAT10 promotes radiotherapy resistance in non-small cell lung cancer by regulating KPNB1-mediated PD-L1 nuclear translocation
  29. Phytol-mixed micelles alleviate dexamethasone-induced osteoporosis in zebrafish: Activation of the MMP3–OPN–MAPK pathway-mediating bone remodeling
  30. Association between TGF-β1 and β-catenin expression in the vaginal wall of patients with pelvic organ prolapse
  31. Primary pleomorphic liposarcoma involving bilateral ovaries: Case report and literature review
  32. Effects of de novo donor-specific Class I and II antibodies on graft outcomes after liver transplantation: A pilot cohort study
  33. Sleep architecture in Alzheimer’s disease continuum: The deep sleep question
  34. Ephedra fragilis plant extract: A groundbreaking corrosion inhibitor for mild steel in acidic environments – electrochemical, EDX, DFT, and Monte Carlo studies
  35. Langerhans cell histiocytosis in an adult patient with upper jaw and pulmonary involvement: A case report
  36. Inhibition of mast cell activation by Jaranol-targeted Pirin ameliorates allergic responses in mouse allergic rhinitis
  37. Aeromonas veronii-induced septic arthritis of the hip in a child with acute lymphoblastic leukemia
  38. Clusterin activates the heat shock response via the PI3K/Akt pathway to protect cardiomyocytes from high-temperature-induced apoptosis
  39. Research progress on fecal microbiota transplantation in tumor prevention and treatment
  40. Low-pressure exposure influences the development of HAPE
  41. Stigmasterol alleviates endplate chondrocyte degeneration through inducing mitophagy by enhancing PINK1 mRNA acetylation via the ESR1/NAT10 axis
  42. AKAP12, mediated by transcription factor 21, inhibits cell proliferation, metastasis, and glycolysis in lung squamous cell carcinoma
  43. Association between PAX9 or MSX1 gene polymorphism and tooth agenesis risk: A meta-analysis
  44. A case of bloodstream infection caused by Neisseria gonorrhoeae
  45. Case of nasopharyngeal tuberculosis complicated with cervical lymph node and pulmonary tuberculosis
  46. p-Cymene inhibits pro-fibrotic and inflammatory mediators to prevent hepatic dysfunction
  47. GFPT2 promotes paclitaxel resistance in epithelial ovarian cancer cells via activating NF-κB signaling pathway
  48. Transfer RNA-derived fragment tRF-36 modulates varicose vein progression via human vascular smooth muscle cell Notch signaling
  49. RTA-408 attenuates the hepatic ischemia reperfusion injury in mice possibly by activating the Nrf2/HO-1 signaling pathway
  50. Decreased serum TIMP4 levels in patients with rheumatoid arthritis
  51. Sirt1 protects lupus nephritis by inhibiting the NLRP3 signaling pathway in human glomerular mesangial cells
  52. Sodium butyrate aids brain injury repair in neonatal rats
  53. Interaction of MTHFR polymorphism with PAX1 methylation in cervical cancer
  54. Convallatoxin inhibits proliferation and angiogenesis of glioma cells via regulating JAK/STAT3 pathway
  55. The effect of the PKR inhibitor, 2-aminopurine, on the replication of influenza A virus, and segment 8 mRNA splicing
  56. Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  57. Small cell lung cancer with small intestinal metastasis: Case report and literature review
  58. GRB14: A prognostic biomarker driving tumor progression in gastric cancer through the PI3K/AKT signaling pathway by interacting with COBLL1
  59. 15-Lipoxygenase-2 deficiency induces foam cell formation that can be restored by salidroside through the inhibition of arachidonic acid effects
  60. FTO alleviated the diabetic nephropathy progression by regulating the N6-methyladenosine levels of DACT1
  61. Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study
  62. Zinc valproic acid complex promotes osteoblast differentiation and exhibits anti-osteoporotic potential
  63. Primary pulmonary synovial sarcoma in the bronchial cavity: A case report
  64. Metagenomic next-generation sequencing of alveolar lavage fluid improves the detection of pulmonary infection
  65. Uterine tumor resembling ovarian sex cord tumor with extensive rhabdoid differentiation: A case report
  66. Genomic analysis of a novel ST11(PR34365) Clostridioides difficile strain isolated from the human fecal of a CDI patient in Guizhou, China
  67. Effects of tiered cardiac rehabilitation on CRP, TNF-α, and physical endurance in older adults with coronary heart disease
  68. Changes in T-lymphocyte subpopulations in patients with colorectal cancer before and after acupoint catgut embedding acupuncture observation
  69. Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment
  70. Alterations of metabolites related to microbiota–gut–brain axis in plasma of colon cancer, esophageal cancer, stomach cancer, and lung cancer patients
  71. Research on individualized drug sensitivity detection technology based on bio-3D printing technology for precision treatment of gastrointestinal stromal tumors
  72. CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway
  73. Oncolytic bacteria: A revolutionary approach to cancer therapy
  74. A de novo meningioma with rapid growth: A possible malignancy imposter?
  75. Diagnosis of secondary tuberculosis infection in an asymptomatic elderly with cancer using next-generation sequencing: Case report
  76. Hesperidin and its zinc(ii) complex enhance osteoblast differentiation and bone formation: In vitro and in vivo evaluations
  77. Research progress on the regulation of autophagy in cardiovascular diseases by chemokines
  78. Anti-arthritic, immunomodulatory, and inflammatory regulation by the benzimidazole derivative BMZ-AD: Insights from an FCA-induced rat model
  79. Immunoassay for pyruvate kinase M1/2 as an Alzheimer’s biomarker in CSF
  80. The role of HDAC11 in age-related hearing loss: Mechanisms and therapeutic implications
  81. Evaluation and application analysis of animal models of PIPNP based on data mining
  82. Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis
  83. Fabrication of zinc oxide nanoparticles using Ruellia tuberosa leaf extract induces apoptosis through P53 and STAT3 signalling pathways in prostate cancer cells
  84. Haplo-hematopoietic stem cell transplantation and immunoradiotherapy for severe aplastic anemia complicated with nasopharyngeal carcinoma: A case report
  85. Modulation of the KEAP1-NRF2 pathway by Erianin: A novel approach to reduce psoriasiform inflammation and inflammatory signaling
  86. The expression of epidermal growth factor receptor 2 and its relationship with tumor-infiltrating lymphocytes and clinical pathological features in breast cancer patients
  87. Innovations in MALDI-TOF Mass Spectrometry: Bridging modern diagnostics and historical insights
  88. BAP1 complexes with YY1 and RBBP7 and its downstream targets in ccRCC cells
  89. Hypereosinophilic syndrome with elevated IgG4 and T-cell clonality: A report of two cases
  90. Electroacupuncture alleviates sciatic nerve injury in sciatica rats by regulating BDNF and NGF levels, myelin sheath degradation, and autophagy
  91. Polydatin prevents cholesterol gallstone formation by regulating cholesterol metabolism via PPAR-γ signaling
  92. RNF144A and RNF144B: Important molecules for health
  93. Analysis of the detection rate and related factors of thyroid nodules in the healthy population
  94. Artesunate inhibits hepatocellular carcinoma cell migration and invasion through OGA-mediated O-GlcNAcylation of ZEB1
  95. Endovascular management of post-pancreatectomy hemorrhage caused by a hepatic artery pseudoaneurysm: Case report and review of the literature
  96. Efficacy and safety of anti-PD-1/PD-L1 antibodies in patients with relapsed refractory diffuse large B-cell lymphoma: A meta-analysis
  97. SATB2 promotes humeral fracture healing in rats by activating the PI3K/AKT pathway
  98. Overexpression of the ferroptosis-related gene, NFS1, corresponds to gastric cancer growth and tumor immune infiltration
  99. Understanding risk factors and prognosis in diabetic foot ulcers
  100. Atractylenolide I alleviates the experimental allergic response in mice by suppressing TLR4/NF-kB/NLRP3 signalling
  101. FBXO31 inhibits the stemness characteristics of CD147 (+) melanoma stem cells
  102. Immune molecule diagnostics in colorectal cancer: CCL2 and CXCL11
  103. Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
  104. Cadmium toxicity, health risk and its remediation using low-cost biochar adsorbents
  105. Pulmonary cryptococcosis with headache as the first presentation: A case report
  106. Solitary pulmonary metastasis with cystic airspaces in colon cancer: A rare case report
  107. RUNX1 promotes denervation-induced muscle atrophy by activating the JUNB/NF-κB pathway and driving M1 macrophage polarization
  108. Morphometric analysis and immunobiological investigation of Indigofera oblongifolia on the infected lung with Plasmodium chabaudi
  109. The NuA4/TIP60 histone-modifying complex and Hr78 modulate the Lobe2 mutant eye phenotype
  110. Experimental study on salmon demineralized bone matrix loaded with recombinant human bone morphogenetic protein-2: In vitro and in vivo study
  111. A case of IgA nephropathy treated with a combination of telitacicept and half-dose glucocorticoids
  112. Analgesic and toxicological evaluation of cannabidiol-rich Moroccan Cannabis sativa L. (Khardala variety) extract: Evidence from an in vivo and in silico study
  113. Wound healing and signaling pathways
  114. Combination of immunotherapy and whole-brain radiotherapy on prognosis of patients with multiple brain metastases: A retrospective cohort study
  115. To explore the relationship between endometrial hyperemia and polycystic ovary syndrome
  116. Research progress on the impact of curcumin on immune responses in breast cancer
  117. Biogenic Cu/Ni nanotherapeutics from Descurainia sophia (L.) Webb ex Prantl seeds for the treatment of lung cancer
  118. Dapagliflozin attenuates atrial fibrosis via the HMGB1/RAGE pathway in atrial fibrillation rats
  119. Glycitein alleviates inflammation and apoptosis in keratinocytes via ROS-associated PI3K–Akt signalling pathway
  120. ADH5 inhibits proliferation but promotes EMT in non-small cell lung cancer cell through activating Smad2/Smad3
  121. Apoptotic efficacies of AgNPs formulated by Syzygium aromaticum leaf extract on 32D-FLT3-ITD human leukemia cell line with PI3K/AKT/mTOR signaling pathway
  122. Novel cuproptosis-related genes C1QBP and PFKP identified as prognostic and therapeutic targets in lung adenocarcinoma
  123. Bee venom promotes exosome secretion and alters miRNA cargo in T cells
  124. Treatment of pure red cell aplasia in a chronic kidney disease patient with roxadustat: A case report
  125. Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status
  126. Kynurenine facilitates renal cell carcinoma progression by suppressing M2 macrophage pyroptosis through inhibition of CASP1 cleavage
  127. RFX5 promotes the growth, motility, and inhibits apoptosis of gastric adenocarcinoma cells through the SIRT1/AMPK axis
  128. ALKBH5 exacerbates early cardiac damage after radiotherapy for breast cancer via m6A demethylation of TLR4
  129. Phytochemicals of Roman chamomile: Antioxidant, anti-aging, and whitening activities of distillation residues
  130. Circadian gene Cry1 inhibits the tumorigenicity of hepatocellular carcinoma by the BAX/BCL2-mediated apoptosis pathway
  131. The TNFR-RIPK1/RIPK3 signalling pathway mediates the effect of lanthanum on necroptosis of nerve cells
  132. Longitudinal monitoring of autoantibody dynamics in patients with early-stage non-small-cell lung cancer undergoing surgery
  133. The potential role of rutin, a flavonoid, in the management of cancer through modulation of cell signaling pathways
  134. Construction of pectinase gene engineering microbe and its application in tobacco sheets
  135. Construction of a microbial abundance prognostic scoring model based on intratumoral microbial data for predicting the prognosis of lung squamous cell carcinoma
  136. Sepsis complicated by haemophagocytic lymphohistiocytosis triggered by methicillin-resistant Staphylococcus aureus and human herpesvirus 8 in an immunocompromised elderly patient: A case report
  137. Sarcopenia in liver transplantation: A comprehensive bibliometric study of current research trends and future directions
  138. Advances in cancer immunotherapy and future directions in personalized medicine
  139. Can coronavirus disease 2019 affect male fertility or cause spontaneous abortion? A two-sample Mendelian randomization analysis
  140. Heat stroke associated with novel leukaemia inhibitory factor receptor gene variant in a Chinese infant
  141. PSME2 exacerbates ulcerative colitis by disrupting intestinal barrier function and promoting autophagy-dependent inflammation
  142. Hyperosmolar hyperglycemic state with severe hypernatremia coexisting with central diabetes insipidus: A case report and literature review
  143. Efficacy and mechanism of escin in improving the tissue microenvironment of blood vessel walls via anti-inflammatory and anticoagulant effects: Implications for clinical practice
  144. Merkel cell carcinoma: Clinicopathological analysis of three patients and literature review
  145. Genetic variants in VWF exon 26 and their implications for type 1 Von Willebrand disease in a Saudi Arabian population
  146. Lipoxin A4 improves myocardial ischemia/reperfusion injury through the Notch1-Nrf2 signaling pathway
  147. High levels of EPHB2 expression predict a poor prognosis and promote tumor progression in endometrial cancer
  148. Knockdown of SHP-2 delays renal tubular epithelial cell injury in diabetic nephropathy by inhibiting NLRP3 inflammasome-mediated pyroptosis
  149. Exploring the toxicity mechanisms and detoxification methods of Rhizoma Paridis
  150. Concomitant gastric carcinoma and primary hepatic angiosarcoma in a patient: A case report
  151. YAP1 inhibition protects retinal vascular endothelial cells under high glucose by inhibiting autophagy
  152. Identification of secretory protein related biomarkers for primary biliary cholangitis based on machine learning and experimental validation
  153. Integrated genomic and clinical modeling for prognostic assessment of radiotherapy response in rectal neoplasms
  154. Stem cell-based approaches for glaucoma treatment: a mini review
  155. Bacteriophage titering by optical density means: KOTE assays
  156. Neutrophil-related signature characterizes immune landscape and predicts prognosis of esophageal squamous cell carcinoma
  157. Integrated bioinformatic analysis and machine learning strategies to identify new potential immune biomarkers for Alzheimer’s disease and their targeting prediction with geniposide
  158. TRIM21 accelerates ferroptosis in intervertebral disc degeneration by promoting SLC7A11 ubiquitination and degradation
  159. TRIM21 accelerates ferroptosis in intervertebral disc degeneration by promoting SLC7A11 ubiquitination and degradation
  160. Histone modification and non-coding RNAs in skin aging: emerging therapeutic avenues
  161. A multiplicative behavioral model of DNA replication initiation in cells
  162. Biogenic gold nanoparticles synthesized from Pergularia daemia leaves: a novel approach for nasopharyngeal carcinoma therapy
  163. Creutzfeldt-Jakob disease mimicking Hashimoto’s encephalopathy: steroid response followed by decline
  164. Impact of semaphorin, Sema3F, on the gene transcription and protein expression of CREB and its binding protein CREBBP in primary hippocampal neurons of rats
  165. Iron overloaded M0 macrophages regulate hematopoietic stem cell proliferation and senescence via the Nrf2/Keap1/HO-1 pathway
  166. Revisiting the link between NADPH oxidase p22phox C242T polymorphism and ischemic stroke risk: an updated meta-analysis
  167. Exercise training preferentially modulates α1D-adrenergic receptor expression in peripheral arteries of hypertensive rats
  168. Overexpression of HE4/WFDC2 gene in mice leads to keratitis and corneal opacity
  169. Tumoral calcinosis complicating CKD-MBD in hemodialysis: a case report
  170. Mechanism of KLF4 Inhibition of epithelial-mesenchymal transition in gastric cancer cells
  171. Dissecting the molecular mechanisms of T cell infiltration in psoriatic lesions via cell-cell communication and regulatory network analysis
  172. Circadian rhythm-based prognostic features predict immune infiltration and tumor microenvironment in molecular subtypes of hepatocellular carcinoma
  173. Ecology and Environmental Science
  174. Optimization and comparative study of Bacillus consortia for cellulolytic potential and cellulase enzyme activity
  175. The complete mitochondrial genome analysis of Haemaphysalis hystricis Supino, 1897 (Ixodida: Ixodidae) and its phylogenetic implications
  176. Epidemiological characteristics and risk factors analysis of multidrug-resistant tuberculosis among tuberculosis population in Huzhou City, Eastern China
  177. Indices of human impacts on landscapes: How do they reflect the proportions of natural habitats?
  178. Genetic analysis of the Siberian flying squirrel population in the northern Changbai Mountains, Northeast China: Insights into population status and conservation
  179. Diversity and environmental drivers of Suillus communities in Pinus sylvestris var. mongolica forests of Inner Mongolia
  180. Global assessment of the fate of nitrogen deposition in forest ecosystems: Insights from 15N tracer studies
  181. Fungal and bacterial pathogenic co-infections mainly lead to the assembly of microbial community in tobacco stems
  182. Influencing of coal industry related airborne particulate matter on ocular surface tear film injury and inflammatory factor expression in Sprague-Dawley rats
  183. Temperature-dependent development, predation, and life table of Sphaerophoria macrogaster (Thomson) (Diptera: Syrphidae) feeding on Myzus persicae (Sulzer) (Homoptera: Aphididae)
  184. Eleonora’s falcon trophic interactions with insects within its breeding range: A systematic review
  185. Agriculture
  186. Integrated analysis of transcriptome, sRNAome, and degradome involved in the drought-response of maize Zhengdan958
  187. Variation in flower frost tolerance among seven apple cultivars and transcriptome response patterns in two contrastingly frost-tolerant selected cultivars
  188. Heritability of durable resistance to stripe rust in bread wheat (Triticum aestivum L.)
  189. Molecular mechanism of follicular development in laying hens based on the regulation of water metabolism
  190. Molecular identification and control studies on Coridius sp. (Hemiptera: Dinidoridae) in Al-Khamra, south of Jeddah, Saudi Arabia
  191. 10.1515/biol-2025-1218
  192. Animal Science
  193. Effect of sex ratio on the life history traits of an important invasive species, Spodoptera frugiperda
  194. Plant Sciences
  195. Hairpin in a haystack: In silico identification and characterization of plant-conserved microRNA in Rafflesiaceae
  196. Widely targeted metabolomics of different tissues in Rubus corchorifolius
  197. The complete chloroplast genome of Gerbera piloselloides (L.) Cass., 1820 (Carduoideae, Asteraceae) and its phylogenetic analysis
  198. Field trial to correlate mineral solubilization activity of Pseudomonas aeruginosa and biochemical content of groundnut plants
  199. Correlation analysis between semen routine parameters and sperm DNA fragmentation index in patients with semen non-liquefaction: A retrospective study
  200. Plasticity of the anatomical traits of Rhododendron L. (Ericaceae) leaves and its implications in adaptation to the plateau environment
  201. Effects of Piriformospora indica and arbuscular mycorrhizal fungus on growth and physiology of Moringa oleifera under low-temperature stress
  202. Effects of different sources of potassium fertiliser on yield, fruit quality and nutrient absorption in “Harward” kiwifruit (Actinidia deliciosa)
  203. Comparative efficiency and residue levels of spraying programs against powdery mildew in grape varieties
  204. The DREB7 transcription factor enhances salt tolerance in soybean plants under salt stress
  205. Using plant electrical signals of water hyacinth (Eichhornia crassipes) for water pollution monitoring
  206. Response of hybrid grapes (Vitis spp.) to two biotic stress factors and their seedlessness status
  207. Metabolomic profiling reveals systemic metabolic reprogramming in Alternaria alternata under salt stress
  208. Effects of mixed salinity and alkali stress on photosynthetic characteristics and PEPC gene expression of vegetable soybean seedlings
  209. Food Science
  210. Phytochemical analysis of Stachys iva: Discovering the optimal extract conditions and its bioactive compounds
  211. Review on role of honey in disease prevention and treatment through modulation of biological activities
  212. Computational analysis of polymorphic residues in maltose and maltotriose transporters of a wild Saccharomyces cerevisiae strain
  213. Optimization of phenolic compound extraction from Tunisian squash by-products: A sustainable approach for antioxidant and antibacterial applications
  214. Liupao tea aqueous extract alleviates dextran sulfate sodium-induced ulcerative colitis in rats by modulating the gut microbiota
  215. Toxicological qualities and detoxification trends of fruit by-products for valorization: A review
  216. Polyphenolic spectrum of cornelian cherry fruits and their health-promoting effect
  217. Optimizing the encapsulation of the refined extract of squash peels for functional food applications: A sustainable approach to reduce food waste
  218. Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies curcuminoid bioavailability and formulations
  219. Impact of saline sprouting on antioxidant properties and bioactive compounds in chia seeds
  220. The dilemma of food genetics and improvement
  221. Causal effects of trace elements on congenital foot deformities and their subtypes: a Mendelian randomization study with gut microbiota mediation
  222. Honey meets acidity: a novel biopreservative approach against foodborne pathogens
  223. Bioengineering and Biotechnology
  224. Impact of hyaluronic acid-modified hafnium metalorganic frameworks containing rhynchophylline on Alzheimer’s disease
  225. Emerging patterns in nanoparticle-based therapeutic approaches for rheumatoid arthritis: A comprehensive bibliometric and visual analysis spanning two decades
  226. Application of CRISPR/Cas gene editing for infectious disease control in poultry
  227. Preparation of hafnium nitride-coated titanium implants by magnetron sputtering technology and evaluation of their antibacterial properties and biocompatibility
  228. Preparation and characterization of lemongrass oil nanoemulsion: Antimicrobial, antibiofilm, antioxidant, and anticancer activities
  229. Fluorescent detection of sialic acid–binding lectins using functionalized quantum dots in ELISA format
  230. Smart tectorigenin-loaded ZnO hydrogel nanocomposites for targeted wound healing: synthesis, characterization, and biological evaluation
  231. Corrigendum
  232. Corrigendum to “Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells”
  233. Corrigendum to “Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  234. Retraction
  235. Retraction of “Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer”
Downloaded on 28.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2025-1221/html?lang=en
Scroll to top button